FDA Accepts New Drug Application for Duvelisib and Grants Priority Review

BOSTON--(BUSINESS WIRE)--Apr. 9, 2018-- Verastem, Inc. (NASDAQ:VSTM), a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the U.S. Food...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news